ginsenoside rh2 has been researched along with Adenocarcinoma of Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, J; Song, W; Yang, X; Yin, H; Yu, D; Zhao, D | 1 |
| Chen, Y; Dong, X; Song, W; Tan, M; Zhang, Y | 1 |
| Li, S; Liu, X; Qi, X; Sun, Y; Yang, Y; Yu, H; Yue, L; Zhang, C; Zhao, H | 1 |
3 other study(ies) available for ginsenoside rh2 and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
Topics: Adenocarcinoma of Lung; beta Catenin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Luciferases; Lung Neoplasms; MicroRNAs; Protein Serine-Threonine Kinases; Wnt Signaling Pathway | 2023 |
Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1.
Topics: A549 Cells; Adenocarcinoma of Lung; Antineoplastic Agents; B7-H1 Antigen; Cisplatin; Drug Synergism; Drugs, Chinese Herbal; Ginsenosides; Humans; Lung Neoplasms; Superoxides | 2020 |
JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
Topics: A549 Cells; Activating Transcription Factor 2; Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Caspase 8; Cell Growth Processes; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Ginsenosides; Humans; Lung Neoplasms; MAP Kinase Signaling System; Transcription Factor AP-1 | 2016 |